The clinical trial is expected to conclude by mid-2025, with top-line data anticipated by year-end 2024. The early results indicate the potential of LP-310 as a breakthrough treatment for OLP, a ...

There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...